PLK1 and lung carcinoma: Thus, combined PLK1/FGFR1 inhibition abolishes ROS homeostasis, leading to oxidative stress‐activated JNK/p38/E2F1 signaling and induction of apoptosis in KRAS‐mutant lung cancer cells.